Merge Bio Therapeutics Corp of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-17. The offering totals $15.0M, of which $5.0M was reported sold. Industry: Other.
| Name | Role | Location |
|---|---|---|
| Steve Liapis | Director | Cambridge, MA |
| Elias Quijano | Director | Cambridge, MA |
| Wesley Wong | Director | Hong Kong, K3 |
| Clinton Hansen | Executive Officer | Bangkok, W1 |
| Wesley Wong | Executive Officer | Hong Kong, K3 |
| Clinton Hansen | Promoter | Bangkok, W1 |
| Mark Lipstein | Promoter | Cambridge, MA |
| Wesley Wong | Promoter | Hong Kong, K3 |
| Darren Yang | Promoter | Cambridge, MA |